{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T12:42:04Z","timestamp":1763988124902,"version":"build-2065373602"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["1 R01CE003039-01-00"],"award-info":[{"award-number":["1 R01CE003039-01-00"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jsat.2020.108247","type":"journal-article","created":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T11:51:58Z","timestamp":1607687518000},"page":"108247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Letting the sun shine on patient voices: Perspectives about medications for opioid use disorder in Florida"],"prefix":"10.1016","volume":"123","author":[{"given":"Amanda","family":"Sharp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Howell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zev","family":"Schuman-Olivier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2020.108247_bb0010","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.drugalcdep.2019.03.014","article-title":"Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths","volume":"200","author":"Barocas","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.jsat.2020.108247_bb0015","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0740-5472(03)00188-0","article-title":"Distance traveled to outpatient drug treatment and client retention","volume":"25","author":"Beardsley","year":"2003","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.jsat.2020.108247_bb0020","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1037\/pha0000325","article-title":"Attitudes toward opioid use disorder medications: Results from a US national study of individuals who resolved a substance use problem","volume":"28","author":"Bergman","year":"2019","journal-title":"Experimental and Clinical Psychopharmacology"},{"author":"Centers for Disease Control and Prevention","key":"10.1016\/j.jsat.2020.108247_bb0030"},{"issue":"2","key":"10.1016\/j.jsat.2020.108247_bb0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/HRP.0000000000000075","article-title":"Medication-assisted treatment of opioid use disorder: Review of the evidence and future directions","volume":"23","author":"Connery","year":"2015","journal-title":"Harvard Review of Psychiatry"},{"year":"2016","series-title":"Qualitative inquiry and research design: Choosing among five approaches","author":"Creswell","key":"10.1016\/j.jsat.2020.108247_bb0045"},{"year":"2008","series-title":"The SAGE encyclopedia of qualitative research methods","author":"Dowling","key":"10.1016\/j.jsat.2020.108247_bb0055"},{"author":"E-FORCSE\u00ae","key":"10.1016\/j.jsat.2020.108247_bb0060"},{"year":"2018","series-title":"Patterns and trends of the opioid epidemic in Florida","author":"Florida Department of Children and Families","key":"10.1016\/j.jsat.2020.108247_bb0065"},{"year":"2019","series-title":"Drugs Identified in Deceased Persons by Florida Medical Examiners (2018 Annual Report)","author":"Florida Department of Law Enforcement","key":"10.1016\/j.jsat.2020.108247_bb0070"},{"author":"Florida Medical Examiners Commission","key":"10.1016\/j.jsat.2020.108247_bb0075"},{"issue":"2","key":"10.1016\/j.jsat.2020.108247_bb0080","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1176\/appi.ps.201300235","article-title":"Medication-assisted treatment with methadone: Assessing the evidence","volume":"65","author":"Fullerton","year":"2014","journal-title":"Psychiatric Services"},{"issue":"9","key":"10.1016\/j.jsat.2020.108247_bb0085","first-page":"1408","article-title":"Are we there yet? Data saturation in qualitative research","volume":"20","author":"Fusch","year":"2015","journal-title":"The Qualitative Report"},{"issue":"3","key":"10.1016\/j.jsat.2020.108247_bb0095","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.pec.2010.02.002","article-title":"From patient education to patient engagement: Implications for the field of patient education","volume":"78","author":"Gruman","year":"2010","journal-title":"Patient Education and Counseling"},{"issue":"1","key":"10.1016\/j.jsat.2020.108247_bb0100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1525822X05279903","article-title":"How many interviews are enough?: An experiment with data saturation and variability","volume":"18","author":"Guest","year":"2006","journal-title":"Field Methods"},{"year":"2012","series-title":"Applied thematic analysis","author":"Guest","key":"10.1016\/j.jsat.2020.108247_bb0105"},{"key":"10.1016\/j.jsat.2020.108247_bb0110","article-title":"Systemic and individual factors in the buprenorphine treatment-seeking process: A qualitative study","volume":"1","author":"Hewell","year":"2017","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"issue":"31","key":"10.1016\/j.jsat.2020.108247_bb0115","article-title":"Addiction and choice: Theory and new data","volume":"4","author":"Heyman","year":"2013","journal-title":"Frontiers in Psychiatry"},{"issue":"1","key":"10.1016\/j.jsat.2020.108247_bb0120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/add.12333","article-title":"Treatment retention among patients randomized to buprenorphine\/naloxone compared to methadone in a multi-site trial","volume":"109","author":"Hser","year":"2014","journal-title":"Addiction-Abingdon"},{"year":"2019","series-title":"SB 366","author":"Infectious Disease Elimination Act (IDEA)","key":"10.1016\/j.jsat.2020.108247_bb9000"},{"issue":"6","key":"10.1016\/j.jsat.2020.108247_bb0125","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3949\/ccjm.80a.12181","article-title":"Medication-assisted treatment of opiate dependence is gaining favor","volume":"80","author":"Jerry","year":"2013","journal-title":"Cleveland Clinic Journal of Medicine"},{"issue":"5\u20136","key":"10.1016\/j.jsat.2020.108247_bb0130","first-page":"347","article-title":"Methadone maintenance treatment (MMT): A review of historical and clinical issues","volume":"67","author":"Joseph","year":"2000","journal-title":"Mount Sinai Journal of Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2020.108247_bb0135","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.amjmed.2014.07.043","article-title":"Stop talking \u201cdirty\u201d: Clinicians, language, and quality of care for the leading cause of preventable death in the United States","volume":"128","author":"Kelly","year":"2015","journal-title":"American Journal of Medicine"},{"issue":"4","key":"10.1016\/j.jsat.2020.108247_bb0140","first-page":"350","article-title":"The role of mutual-help groups in extending the framework of treatment","volume":"33","author":"Kelly","year":"2011","journal-title":"Alcohol Research & Health: The Journal of the National Institute on Alcohol Abuse and Alcoholism"},{"issue":"1","key":"10.1016\/j.jsat.2020.108247_bb0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/ADM.0b013e3181d41ddb","article-title":"Adoption and implementation of medications in addiction treatment programs","volume":"5","author":"Knudsen","year":"2011","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.jsat.2020.108247_bb0150","article-title":"The role of social network support on treatment outcomes for medication for opioid use disorder: A systematic review","author":"Kumar","year":"2020","journal-title":"medRxiv"},{"issue":"21","key":"10.1016\/j.jsat.2020.108247_bb0155","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1001\/jama.2019.5523","article-title":"Medication-based treatment to address opioid use disorder","volume":"321","author":"Leshner","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jsat.2020.108247_bb0160","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12875-019-1047-z","article-title":"Attitudes of primary care physicians toward prescribing buprenorphine: A narrative review","volume":"20","author":"Louie","year":"2019","journal-title":"BMC Family Practice"},{"key":"10.1016\/j.jsat.2020.108247_bb0165","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.socscimed.2019.05.027","article-title":"Intervention stigma: How medication-assisted treatment marginalizes patients and providers","volume":"232","author":"Madden","year":"2019","journal-title":"Social Science and Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2020.108247_bb0175","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13722-018-0123-3","article-title":"Closing the gaps in opioid use disorder research, policy and practice: Conference proceedings","volume":"13","author":"Miclette","year":"2018","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.jsat.2020.108247_bb0180","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jsat.2019.08.006","article-title":"Patient decision aid for medication treatment for opioid use disorder (PtDA-MOUD): Rationale, methodology, and preliminary results","volume":"108","author":"Mooney","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.jsat.2020.108247_bb0185","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jsat.2004.03.010","article-title":"The impact of motivational interviewing on substance abuse treatment retention: A randomized control trial of women involved with child welfare","volume":"27","author":"Mullins","year":"2004","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.jsat.2020.108247_bb0190","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/08897077.2014.941085","article-title":"Exploring the concepts of abstinence and recovery through the experiences of long-term opiate substitution clients","volume":"36","author":"Notley","year":"2015","journal-title":"Substance Abuse"},{"issue":"8","key":"10.1016\/j.jsat.2020.108247_bb0195","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s11606-016-3685-3","article-title":"Motivational interviewing improves medication adherence: A systematic review and meta-analysis","volume":"31","author":"Palacio","year":"2016","journal-title":"Journal of General Internal Medicine"},{"issue":"2","key":"10.1016\/j.jsat.2020.108247_bb0200","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/add.13193","article-title":"Impact of treatment for opioid dependence on fatal drug-related poisoning: A national cohort study in England","volume":"111","author":"Pierce","year":"2016","journal-title":"Addiction-Abingdon"},{"issue":"2","key":"10.1016\/j.jsat.2020.108247_bb0205","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jsat.2006.09.002","article-title":"Client and counselor attitudes toward the use of medications for treatment of opioid dependence","volume":"32","author":"Rieckmann","year":"2007","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.jsat.2020.108247_bb0210","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11414-017-9553-z","article-title":"Treating opioid dependence with buprenorphine in the safety net: Critical learning from clinical data","volume":"44","author":"Rieckmann","year":"2017","journal-title":"Journal of Behavioral Health Services & Research"},{"issue":"7","key":"10.1016\/j.jsat.2020.108247_bb0215","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1177\/1049732313488837","article-title":"Understanding the etiology of prescription opioid abuse: Implications for prevention and treatment","volume":"23","author":"Rigg","year":"2013","journal-title":"Qualitative Health Research"},{"issue":"6","key":"10.1016\/j.jsat.2020.108247_bb0220","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.addbeh.2011.01.032","article-title":"Using medication-assisted treatment for substance use disorders: Evidence of barriers and facilitators of implementation","volume":"36","author":"Roman","year":"2011","journal-title":"Addictive Behaviors"},{"issue":"4","key":"10.1016\/j.jsat.2020.108247_bb0225","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1007\/s11135-017-0574-8","article-title":"Saturation in qualitative research: Exploring its conceptualization and operationalization","volume":"52","author":"Saunders","year":"2018","journal-title":"Quality & Quantity"},{"issue":"1","key":"10.1016\/j.jsat.2020.108247_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13722-018-0122-4","article-title":"MySafeRx: A mobile technology platform integrating motivational coaching, adherence monitoring, and electronic pill dispensing for enhancing buprenorphine\/naloxone adherence during opioid use disorder treatment: A pilot study","volume":"13","author":"Schuman-Olivier","year":"2018","journal-title":"Addiction Science & Clinical Practice"},{"issue":"5","key":"10.1016\/j.jsat.2020.108247_bb0235","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/10550490802268835","article-title":"Attitudes toward buprenorphine and methadone among opioid-dependent individuals","volume":"17","author":"Schwartz","year":"2008","journal-title":"The American Journal on Addictions"},{"issue":"4","key":"10.1016\/j.jsat.2020.108247_bb0240","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jamapsychiatry.2013.4450","article-title":"Access to treatment for opioid dependence in rural America: Challenges and future directions","volume":"71","author":"Sigmon","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.jsat.2020.108247_bb0245","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/08897077.2017.1353570","article-title":"Overdose history is associated with post-detoxification treatment preference for persons with opioid use disorder","volume":"38","author":"Stein","year":"2017","journal-title":"Substance Abuse"},{"author":"Substance Abuse and Mental Health Services Administration (SAMHSA)","key":"10.1016\/j.jsat.2020.108247_bb0250"},{"author":"Substance Abuse and Mental Health Services Administration (SAMHSA)","key":"10.1016\/j.jsat.2020.108247_bb0255"},{"issue":"2","key":"10.1016\/j.jsat.2020.108247_bb0260","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1176\/appi.ajp.2018.17070732","article-title":"A randomized trial comparing extended-release injectable suspension and oral naltrexone, both combined with behavioral therapy, for the treatment of opioid use disorder","volume":"176","author":"Sullivan","year":"2019","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.jsat.2020.108247_bb0265","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10550887.2016.1100960","article-title":"Retention in medication-assisted treatment for opiate dependence: A systematic review","volume":"35","author":"Timko","year":"2016","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.jsat.2020.108247_bb0275","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jsat.2016.02.009","article-title":"Patients\u2019 beliefs about medications are associated with stated preference for methadone, buprenorphine, naltrexone, or no medication-assisted therapy following inpatient opioid detoxification","volume":"66","author":"Uebelacker","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.jsat.2020.108247_bb0280","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/nhs.12048","article-title":"Content analysis and thematic analysis: Implications for conducting a qualitative descriptive study","volume":"15","author":"Vaismoradi","year":"2013","journal-title":"Nursing & Health Sciences"},{"issue":"22","key":"10.1016\/j.jsat.2020.108247_bb0285","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies - Tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.jsat.2020.108247_bb0290","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMra1511480","article-title":"Neurobiologic advances from the brain disease model of addiction","volume":"374","author":"Volkow","year":"2016","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2020.108247_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ADM.0000000000000275","article-title":"Medications for addiction treatment: Changing language to improve care","volume":"11","author":"Wakeman","year":"2017","journal-title":"Journal of Addiction Medicine"},{"issue":"2","key":"10.1016\/j.jsat.2020.108247_bb0300","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/10826084.2017.1363238","article-title":"Barriers to medications for addiction treatment: How stigma kills","volume":"53","author":"Wakeman","year":"2018","journal-title":"Substance Use and Misuse"},{"issue":"9","key":"10.1016\/j.jsat.2020.108247_bb0305","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.addbeh.2012.04.011","article-title":"Predictors of attrition with buprenorphine\/naloxone treatment in opioid dependent youth","volume":"37","author":"Warden","year":"2012","journal-title":"Addictive Behaviors"},{"issue":"3","key":"10.1016\/j.jsat.2020.108247_bb0310","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/10550887.2012.694597","article-title":"Medication-assisted recovery from opioid addiction: Historical and contemporary perspectives","volume":"31","author":"White","year":"2012","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.jsat.2020.108247_bb0315","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2015.12.031","article-title":"Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis","volume":"160","author":"Yarborough","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.jsat.2020.108247_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13011-020-00288-0","article-title":"Stigma: How it affects the substance use disorder patient","volume":"15","author":"Zwick","year":"2020","journal-title":"Substance Abuse Treatment, Prevention, and Policy"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547220305043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547220305043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:52:09Z","timestamp":1760039529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547220305043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":58,"alternative-id":["S0740547220305043"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2020.108247","relation":{},"ISSN":["0740-5472"],"issn-type":[{"type":"print","value":"0740-5472"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Letting the sun shine on patient voices: Perspectives about medications for opioid use disorder in Florida","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2020.108247","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108247"}}